Daewoong, Binex to join forces in R&D

Published: 2011-05-25 06:57:00

Updated: 2011-05-25 06:57:00

Daewoong Pharmaceutical and Binex Co. have agreed to join hands to jointly develop new rheumatoid arthritis drug and biosimilars so that the two companies can stay competitive at home and abroad.

The two companies signed a strategic agreement Monday to conduct a joint research for the developm...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK